Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bellerophon Therapeutics, Inc. (BLPH) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bellerophon Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1600132.
Total stock buying since 2015: $57,106,300.
Total stock sales since 2015: $8,858,570.
Total stock option exercises since 2015: $10,053.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 1,780,717 | $5,615,710 | 1,288 | $9,563 |
| 2021 | 0 | $0 | 400,000 | $2,192,000 | 0 | $0 |
| 2020 | 11,586 | $137,603 | 0 | $0 | 0 | $0 |
| 2019 | 2,175,652 | $1,508,200 | 2,187,694 | $1,050,860 | 0 | $0 |
| 2018 | 2,538,740 | $2,331,497 | 0 | $0 | 0 | $0 |
| 2017 | 715,394 | $0 | 0 | $0 | 1,000 | $490 |
| 2016 | 1,167,857 | $18,040 | 0 | $0 | 0 | $0 |
| 2015 | 4,446,034 | $53,110,960 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-10 | 0 | $0 | 1,076,841 | $111,991 | 0 | $0 |
| 2023-06 | 0 | $0 | 134,421 | $111,569 | 0 | $0 |
| 2023-05 | 0 | $0 | 569,455 | $5,392,150 | 1,288 | $9,563 |
| 2021-03 | 0 | $0 | 400,000 | $2,192,000 | 0 | $0 |
| 2020-09 | 4,000 | $40,708 | 0 | $0 | 0 | $0 |
| 2020-06 | 7,586 | $96,895 | 0 | $0 | 0 | $0 |
| 2019-11 | 8,443 | $3,243 | 0 | $0 | 0 | $0 |
| 2019-10 | 0 | $0 | 2,187,694 | $1,050,860 | 0 | $0 |
| 2019-06 | 50,000 | $31,900 | 0 | $0 | 0 | $0 |
| 2019-05 | 95,780 | $58,059 | 0 | $0 | 0 | $0 |
| 2019-01 | 2,021,429 | $1,414,998 | 0 | $0 | 0 | $0 |
| 2018-09 | 1,480,000 | $1,645,463 | 0 | $0 | 0 | $0 |
| 2018-08 | 1,058,740 | $686,034 | 0 | $0 | 0 | $0 |
| 2017-12 | 0 | $0 | 0 | $0 | 1,000 | $490 |
| 2017-09 | 715,394 | $0 | 0 | $0 | 0 | $0 |
| 2016-12 | 20,000 | $11,200 | 0 | $0 | 0 | $0 |
| 2016-11 | 1,142,857 | $0 | 0 | $0 | 0 | $0 |
| 2016-05 | 5,000 | $6,840 | 0 | $0 | 0 | $0 |
| 2015-12 | 20,300 | $55,740 | 0 | $0 | 0 | $0 |
| 2015-08 | 5,000 | $27,375 | 0 | $0 | 0 | $0 |
| 2015-05 | 6,272 | $54,301 | 0 | $0 | 0 | $0 |
| 2015-02 | 4,414,462 | $52,973,544 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-13 | Wang Theodore T (10% Owner) | Sale | 1,076,841 | .10 | 111,991 |
| 2023-06-07 | Wang Theodore T (Director) | Sale | 134,421 | .83 | 111,569 |
| 2023-05-18 | Kim Bobae (VP Reg. Affairs & Quality) | Sale | 9,455 | 10.00 | 94,550 |
| 2023-05-18 | Kim Bobae (VP Reg. Affairs & Quality) | Option Ex | 1,288 | 7.42 | 9,563 |
| 2023-05-18 | Puissance Capital Management Lp (10% Owner) | Sale | 560,000 | 9.46 | 5,297,600 |
| 2021-03-18 | Klinsky Steven B | Sale | 400,000 | 5.48 | 2,192,000 |
| 2020-09-10 | Fares Wassim (Chief Medical Officer) | Buy | 4,000 | 10.18 | 40,708 |
| 2020-06-08 | Wang Theodore T | Buy | 2,600 | 12.87 | 33,454 |
| 2020-06-05 | Wang Theodore T | Buy | 4,986 | 12.72 | 63,441 |
| 2019-11-25 | Wang Theodore T | Buy | 7,193 | .39 | 2,776 |
| 2019-11-22 | Wang Theodore T | Buy | 1,050 | .38 | 393 |
| 2019-11-21 | Wang Theodore T | Buy | 200 | .37 | 74 |
| 2019-10-28 | Vhcp Management Iii, Llc (10% Owner) | Sale | 333,010 | .44 | 146,191 |
| 2019-10-28 | Vhcp Management Ii, Llc (10% Owner) | Sale | 333,010 | .44 | 146,191 |
| 2019-10-25 | Vhcp Management Iii, Llc (10% Owner) | Sale | 56,242 | .45 | 25,533 |
| 2019-10-25 | Vhcp Management Ii, Llc (10% Owner) | Sale | 56,242 | .45 | 25,533 |
| 2019-10-24 | Vhcp Management Iii, Llc (10% Owner) | Sale | 704,595 | .50 | 353,706 |
| 2019-10-24 | Vhcp Management Ii, Llc (10% Owner) | Sale | 704,595 | .50 | 353,706 |
| 2019-06-12 | Wang Theodore T | Buy | 50,000 | .64 | 31,900 |
| 2019-05-22 | Wang Theodore T | Buy | 27,500 | .60 | 16,527 |
| 2019-05-21 | Wang Theodore T | Buy | 43,280 | .61 | 26,357 |
| 2019-05-21 | Tenenbaum Fabian (Chief Executive Officer) | Buy | 5,000 | .59 | 2,975 |
| 2019-05-21 | Peacock Jonathan M | Buy | 20,000 | .61 | 12,200 |
| 2019-01-25 | Wang Theodore T | Buy | 450,000 | .70 | 315,000 |
| 2019-01-25 | Amin Naseem | Buy | 571,429 | .70 | 400,000 |
| 2019-01-25 | Peacock Jonathan M | Buy | 714,286 | .70 | 500,000 |
| 2019-01-23 | Vhcp Management Iii, Llc (10% Owner) | Buy | 142,857 | .70 | 99,999 |
| 2019-01-23 | Koh Bong Y (10% Owner) | Buy | 142,857 | .70 | 99,999 |
| 2018-09-17 | Koh Bong Y (10% Owner) | Buy | 60,000 | 1.18 | 70,920 |
| 2018-09-14 | Koh Bong Y (10% Owner) | Buy | 75,000 | 1.23 | 92,250 |
| 2018-09-13 | Koh Bong Y (10% Owner) | Buy | 75,000 | 1.19 | 89,175 |
| 2018-09-12 | Shah Nimish P (10% Owner) | Buy | 75,000 | 1.15 | 85,950 |
| 2018-09-12 | Koh Bong Y (10% Owner) | Buy | 75,000 | 1.15 | 85,950 |
| 2018-09-11 | Shah Nimish P (10% Owner) | Buy | 200,000 | 1.14 | 228,799 |
| 2018-09-11 | Koh Bong Y (10% Owner) | Buy | 200,000 | 1.14 | 228,799 |
| 2018-09-10 | Shah Nimish P (10% Owner) | Buy | 200,000 | 1.22 | 243,600 |
| 2018-09-10 | Koh Bong Y (10% Owner) | Buy | 200,000 | 1.22 | 243,600 |
| 2018-09-07 | Shah Nimish P (10% Owner) | Buy | 60,000 | .90 | 53,760 |
| 2018-09-07 | Koh Bong Y (10% Owner) | Buy | 60,000 | .90 | 53,760 |
| 2018-09-06 | Shah Nimish P (10% Owner) | Buy | 50,000 | .84 | 42,100 |
| 2018-09-06 | Koh Bong Y (10% Owner) | Buy | 50,000 | .84 | 42,100 |
| 2018-09-05 | Shah Nimish P (10% Owner) | Buy | 50,000 | .85 | 42,350 |
| 2018-09-05 | Koh Bong Y (10% Owner) | Buy | 50,000 | .85 | 42,350 |
| 2018-08-16 | Shah Nimish P (10% Owner) | Buy | 66,393 | .65 | 43,089 |
| 2018-08-16 | Koh Bong Y (10% Owner) | Buy | 66,393 | .65 | 43,089 |
| 2018-08-15 | Shah Nimish P (10% Owner) | Buy | 272,000 | .65 | 175,984 |
| 2018-08-15 | Koh Bong Y (10% Owner) | Buy | 272,000 | .65 | 175,984 |
| 2018-08-14 | Shah Nimish P (10% Owner) | Buy | 190,977 | .65 | 123,944 |
| 2018-08-14 | Koh Bong Y (10% Owner) | Buy | 190,977 | .65 | 123,944 |
| 2017-12-13 | Schoeps Megan (Principal Financial Officer) | Option Ex | 1,000 | .49 | 490 |
| 2017-09-29 | Amin Naseem | Buy | 456,432 | .00 | 0 |
| 2017-09-29 | Luehring Jens | Buy | 10,000 | .00 | 0 |
| 2017-09-29 | Peacock Jonathan M | Buy | 248,962 | .00 | 0 |
| 2016-12-09 | Luehring Jens | Buy | 20,000 | .56 | 11,200 |
| 2016-11-29 | Amin Naseem | Buy | 714,285 | .00 | 0 |
| 2016-11-29 | Tenenbaum Fabian (Chief Executive Officer) | Buy | 142,857 | .00 | 0 |
| 2016-11-29 | Peacock Jonathan M | Buy | 285,715 | .00 | 0 |
| 2016-05-17 | Peacock Jonathan M (President and CEO) | Buy | 5,000 | 1.37 | 6,840 |
| 2015-12-16 | Peacock Jonathan M (President and CEO) | Buy | 12,800 | 2.76 | 35,340 |
| 2015-12-15 | Peacock Jonathan M (President and CEO) | Buy | 7,500 | 2.72 | 20,400 |
| 2015-08-19 | Peacock Jonathan M (President and CEO) | Buy | 5,000 | 5.47 | 27,375 |
| 2015-05-20 | Peacock Jonathan M (President and CEO) | Buy | 5,560 | 8.69 | 48,321 |
| 2015-05-20 | Meglasson Martin (Chief Scientific Officer) | Buy | 712 | 8.40 | 5,980 |
| 2015-02-19 | Holt Matthew S. (Director) | Buy | 1,070,166 | 12.00 | 12,841,992 |
| 2015-02-19 | Luehring Jens (Director) | Buy | 358,916 | 12.00 | 4,306,992 |
| 2015-02-19 | Naidu Manesh (Chief Business Officer) | Buy | 1,500 | 12.00 | 18,000 |
| 2015-02-19 | Heyrman Reinilde (Chief Clinical Dev. Officer) | Buy | 1,500 | 12.00 | 18,000 |
| 2015-02-19 | Weinstein Adam (Director) | Buy | 1,070,166 | 12.00 | 12,841,992 |
| 2015-02-19 | Linde North America, Inc. (10% Owner) | Buy | 358,916 | 12.00 | 4,306,992 |
| 2015-02-19 | Tasse Daniel (Director) | Buy | 25,000 | 12.00 | 300,000 |
| 2015-02-19 | Peacock Jonathan M (President and CEO) | Buy | 20,800 | 12.00 | 249,600 |
| 2015-02-19 | Meglasson Martin (Chief Scientific Officer) | Buy | 12,000 | 12.00 | 144,000 |
| 2015-02-19 | Bybee Clinton (10% Owner) | Buy | 212,666 | 12.00 | 2,551,992 |
| 2015-02-19 | Nelsen Robert (Director) | Buy | 212,666 | 12.00 | 2,551,992 |
| 2015-02-19 | Klinsky Steven B (10% Owner) | Buy | 1,070,166 | 12.00 | 12,841,992 |
Insider trading activities including stock purchases, stock sales, and option exercises of BLPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bellerophon Therapeutics, Inc. (symbol BLPH, CIK number 1600132) see the Securities and Exchange Commission (SEC) website.